As the core regulator of metabolic and translational reprogramming, mTOR is mainly involved in the central tumor immune microenvironment, affecting tumor-associated immune cells to undergo phenotypic and functional reprogramming in TME. The gene discussed is MTOR; the disease is neoplasm.